Fig. 1

a All measured values in ROTEM analysis, including clotting time (CT [s]), clot formation time (CFT [s]), maximum clot firmness (MCF [mm]) and maximum lysis (ML [%(range)]). b A reduction of fibrinolysis in a COVID-19 patient with a thromboembolic event; the clot amplitude remains unchanged until the end. c A physiological fibrinolysis pattern in a healthy person, reflected by the subtle decrease of the MCF during the measurement